Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitabilityReportar como inadecuado




Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Cancer

, 10:451

Clinical oncology

Abstract

BackgroundPlatinum-based drugs, such as cisplatin and oxaliplatin, are well-known for inducing chronic sensory neuropathies but their acute and motor neurotoxicities are less well characterised. Use was made of nerve conduction studies and needle electromyography EMG to assess motor nerve excitability in cancer patients during their first treatment cycle with platinum-based chemotherapy in this study.

MethodsTwenty-nine adult cancer patients had a neurophysiological assessment either before oxaliplatin plus capecitabine, on days 2 to 4 or 14 to 20 after oxaliplatin plus capecitabine, or on days 2 to 4 after carboplatin plus paclitaxel or cisplatin, undertaken by a neurophysiologist who was blinded to patient and treatment details. Patients completed a symptom questionnaire at the end of the treatment cycle.

ResultsAbnormal spontaneous high frequency motor fibre action potentials were detected in 100% of patients n = 6 and 72% of muscles n = 22 on days 2 to 4 post-oxaliplatin, and in 25% of patients n = 8 and 13% of muscles n = 32 on days 14 to 20 post-oxaliplatin, but in none of the patients n = 14 or muscles n = 56 tested prior to oxaliplatin or on days 2 to 4 after carboplatin plus paclitaxel or cisplatin. Repetitive compound motor action potentials were less sensitive and less specific than spontaneous high frequency motor fibre action potentials for detection of acute oxaliplatin-induced motor nerve hyperexcitability but were present in 71% of patients n = 7 and 32% of muscles n = 32 on days 2 to 4 after oxaliplatin treatment. Acute neurotoxicity symptoms, most commonly cold-induced paraesthesiae and jaw or throat tightness, were reported by all patients treated with oxaliplatin n = 22 and none of those treated with carboplatin plus paclitaxel or cisplatin n = 6.

ConclusionsAbnormal spontaneous high frequency motor fibre activity is a sensitive and specific endpoint of acute oxaliplatin-induced motor nerve hyperexcitability, detectable on EMG on days 2 to 4 post-treatment. Objective EMG assessment of motor nerve excitability could compliment patient-reported symptomatic endpoints of acute oxaliplatin-induced neurotoxicity in future studies.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2407-10-451 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Autor: Andrew Hill - Peter Bergin - Fritha Hanning - Paul Thompson - Michael Findlay - Dragan Damianovich - Mark J McKeage

Fuente: https://link.springer.com/







Documentos relacionados